{
  "schemaVersion": 1,
  "contentDigest": "99bd3c83892a9433d0e8771102ccee95694c9067cadde6d4493403455496ffd5",
  "id": "news-oct22-a2-abu-dhabi-ai-cancer-drug-discovery-partnership-2026-10-20",
  "language": "es",
  "interfaceLanguage": "es",
  "url": "https://voltformer.com/es/news/burjeel-avatrial-explore-ai-cancer-drug-discovery-abu-dhabi",
  "slug": "burjeel-avatrial-explore-ai-cancer-drug-discovery-abu-dhabi",
  "category": "policy-standards",
  "publishDate": "2026-10-20",
  "sourceName": "Emirates News Agency (WAM)",
  "sourceUrl": "https://www.wam.ae/en/article/c2u6plc-burjeel-avatrial-partner-develop-first-of-its-kind",
  "readingTimeMinutes": 1,
  "tags": [
    "Emiratos Árabes Unidos",
    "Inteligencia artificial",
    "Biotecnología",
    "Productos farmacéuticos"
  ],
  "content": {
    "title": "Burjeel y Avatrial exploran investigación oncológica con IA en Abu Dabi",
    "summary": "El memorando es exploratorio y no fija inversión comprometida ni fecha de inicio.",
    "sections": [
      {
        "paragraphs": [
          "Burjeel Holdings y la biotecnológica británica Avatrial firmaron un memorando para explorar fármacos contra el cáncer con IA en Abu Dabi. La propuesta uniría experiencia clínica de Burjeel e investigación de Avatrial; no anunciaron inversión ni fecha de inicio."
        ],
        "sources": [
          {
            "name": "Emirates News Agency (WAM)",
            "url": "https://www.wam.ae/en/article/c2u6plc-burjeel-avatrial-partner-develop-first-of-its-kind"
          }
        ]
      }
    ],
    "tags": [
      "Emiratos Árabes Unidos",
      "Inteligencia artificial",
      "Biotecnología",
      "Productos farmacéuticos"
    ]
  },
  "companies": [],
  "sourceVersion": "c8bf006d57c2fe16f4f7a41f3cf4333d2726e27ddf1b3b7a5e25f4d0b5402813"
}